Work

Pertuzumab + trastuzumab for HER2-positive metastatic biliary cancer: Preliminary data from MyPathway.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.4_suppl.402

Authors: Milind M. Javle, John D. Hainsworth, Charles Swanton, Howard A. Burris, Razelle Kurzrock, Christopher Sweeney, Funda Meric-Bernstam, David R. Spigel, Ron Bose, Shuangli Guo, Coen Bernaards, Mary Stanley Beattie, Frank A. Scappaticci, Herbert Hurwitz

Institutions: The University of Texas MD Anderson Cancer Center, Tennessee Oncology, The Francis Crick Institute, University of California San Diego, Moores Cancer Center, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Washington University in St. Louis, Sarah Cannon, Genentech, Duke Medical Center

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603694770

Cites:

Cited by: 58

Related to: 10